Trial
NCT00936663
Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Nebraska
Collaborators
—
Condition
Type 2 Diabetes
Intervention
Placebo
Why stopped
lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-13